These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1236952)
1. Analogs of bradykinin with restricted conformational freedom. Turk J; Needleman P; Marshall GR J Med Chem; 1975 Nov; 18(11):1139-42. PubMed ID: 1236952 [TBL] [Abstract][Full Text] [Related]
2. Alkylating analogs of bradykinin. Turk J; Needleman P; Marshall GR J Med Chem; 1975 Nov; 18(11):1135-9. PubMed ID: 240938 [TBL] [Abstract][Full Text] [Related]
3. Development of bradykinin antagonists: structure-activity relationships for new categories of antagonist sequences. Vavrek RJ; Stewart JM Adv Exp Med Biol; 1989; 247B():395-400. PubMed ID: 2610083 [No Abstract] [Full Text] [Related]
5. L-3,4-dehydroproline analogs of bradykinin. Synthesis, biological activity, and solution conformation. Fisher GH; Marlborough DI; Ryan JW; Felix AM Arch Biochem Biophys; 1978 Jul; 189(1):81-5. PubMed ID: 708052 [No Abstract] [Full Text] [Related]
6. Synthesis and pharmacological properties of [5-isoleucine]-, [8-isoleucine]-, and [5,8-diisoleucine]bradykinin. Chiu AT; Day AR; Radding JA; Freer RJ J Med Chem; 1979 Mar; 22(3):334-5. PubMed ID: 423219 [TBL] [Abstract][Full Text] [Related]
7. Highly selective bradykinin agonists and antagonists with replacement of proline residues by N-methyl-D- and L-phenylalanine. Reissmann S; Schwuchow C; Seyfarth L; Pineda De Castro LF; Liebmann C; Paegelow I; Werner H; Stewart JM J Med Chem; 1996 Feb; 39(4):929-36. PubMed ID: 8632416 [TBL] [Abstract][Full Text] [Related]
8. New bradykinin B(2) receptor antagonists - influence of C-terminal segment modifications on their pharmacological properties. Sleszyńska M; Kwiatkowska A; Sobolewski D; Wierzba TH; Katarzyńska J; Zabrocki J; Borovickova L; Slaninová J; Prahl A Acta Biochim Pol; 2009; 56(4):641-8. PubMed ID: 19997652 [TBL] [Abstract][Full Text] [Related]
9. New bradykinin analogs in contraction of rat uterus. Trzeciak HI; Kozik W; Melhem S; Kania A; Dobrowolski D; Prahl A; Derdowska I; Lammek B Peptides; 2000 Jun; 21(6):829-34. PubMed ID: 10959005 [TBL] [Abstract][Full Text] [Related]
10. New bradykinin analogues modified in the C-terminal part with sterically restricted 1-aminocyclohexane-1-carboxylic acid. Labudda-Dawidowska O; Wierzba TH; Prahl A; Kowalczyk W; Gawiński Ł; Plackova M; Slaninová J; Lammek B J Med Chem; 2005 Dec; 48(25):8055-9. PubMed ID: 16335929 [TBL] [Abstract][Full Text] [Related]
11. [Biologically active loop-shaped analogs of bradykinin and polisteskinin]. Mutule IE; Mutulis FK; Lando OE; Ashmanis AA; Grigor'eva VD Bioorg Khim; 1984 Jul; 10(7):891-901. PubMed ID: 6497913 [TBL] [Abstract][Full Text] [Related]
12. Pseudopeptide analogs of bradykinin and bradykinin antagonists. Vavrek RJ; Gera L; Stewart JM Agents Actions Suppl; 1992; 38 ( Pt 1)():565-71. PubMed ID: 1466297 [TBL] [Abstract][Full Text] [Related]
13. Bradykinin competitive antagonists for classical kinin systems. Stewart JM; Vavrek RJ Adv Exp Med Biol; 1986; 198 Pt A():537-42. PubMed ID: 3812091 [TBL] [Abstract][Full Text] [Related]
14. Bradykinin antagonists do not require a D-aromatic amino acid residue at position 7. Vavrek RJ; Gera L; Stewart JM Agents Actions Suppl; 1992; 38 ( Pt 1)():572-81. PubMed ID: 1466298 [TBL] [Abstract][Full Text] [Related]
15. New bradykinin analogues substituted in positions 7 and 8 with sterically restricted 1-aminocyclopentane-1-carboxylic acid. Labudda O; Wierzba T; Sobolewski D; Kowalczyk W; Sleszyńska M; Gawiński L; Plackova M; Slaninová J; Prahl A J Pept Sci; 2006 Dec; 12(12):775-9. PubMed ID: 17131289 [TBL] [Abstract][Full Text] [Related]